Top Biotechnology & Medical Research stocks in Australasia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
TLXTelix Pharmaceuticals	AU$4.89bn	78.02	n/a
MSBMesoblast	AU$2.51bn	n/a	n/a
CU6Clarity Pharmaceuticals	AU$956.02m	n/a	n/a
PYCPYC Therapeutics	AU$746.57m	n/a	n/a
IMMImmutep	AU$342.06m	n/a	n/a
CGSCogstate	AU$293.98m	26.3	n/a
DXBDimerix	AU$251.04m	n/a	n/a
TTXTetratherix	AU$209.88m	n/a	n/a
RACRace Oncology	AU$207.59m	n/a	n/a
PARParadigm Biopharmaceuticals	AU$114.88m	n/a	n/a
ALAArovella Therapeutics	AU$103.41m	n/a	n/a
BXNBioxyne	AU$102.46m	37.88	n/a
PEBPacific Edge	NZ$113.67m	n/a	n/a
ACWActinogen Medical	AU$90.85m	n/a	n/a
LTPLtr Pharma	AU$87.77m	n/a	n/a
AGNArgenica Therapeutics	AU$82.62m	n/a	n/a
ATHAlterity Therapeutics	AU$74.48m	n/a	n/a
ATXAmplia Therapeutics	AU$64.01m	n/a	n/a
IMUImugene	AU$62.36m	n/a	n/a
ADOAnteotech	AU$62.22m	n/a	n/a